Location: New York, NY
CIK: 0001615982 · Show all filings
Period: Q4 2025 (← Previous) (Next →)
Filing Date: Feb 17, 2026
Total Value: $2.025B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| APGE | APOGEE THERAPEUTICS INC | 8,493,321 | $641M | 31.7% | $22.03 | +185.9% | COM | 03770N101 |
| ORKA | ORUKA THERAPEUTICS INC | 4,148,428 | $126M | 6.2% | $29.65 | -6.0% | COM | 687604108 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 3,882,709 | $121M | 6.0% | $19.32 | +42.0% | COM | 92790C104 |
| SYRE | SPYRE THERAPEUTICS INC | 3,685,448 | $121M | 6.0% | $19.91 | +31.2% | COM NEW | 00773J202 |
| KALV | KALVISTA PHARMACEUTICALS INC | 6,728,985 | $109M | 5.4% | $8.91 | +48.7% | COM | 483497103 |
| OCUL | OCULAR THERAPEUTIX INC | 7,315,547 | $88.81M | 4.4% | $4.80 | +153.1% | COM | 67576A100 |
| SVRA | SAVARA INC | 13,740,375 | $82.85M | 4.1% | $2.96 | +65.3% | COM | 805111101 |
| COGT | COGENT BIOSCIENCES INC | 2,000,000 | $71.04M | 3.5% | $8.47 | +232.1% | COM | 19240Q201 |
| ERAS | ERASCA INC | 17,857,083 | $66.43M | 3.3% | $2.08 | +35.1% | COM | 29479A108 |
| CTMX | CYTOMX THERAPEUTICS INC | 15,561,500 | $66.29M | 3.3% | $1.68 | +126.5% | COM | 23284F105 |
| MAZE | MAZE THERAPEUTICS INC | 1,548,569 | $64.16M | 3.2% | $20.47 | +67.9% | COM | 578784100 |
| JBIO | JADE BIOSCIENCES INC | 3,220,364 | $49.69M | 2.5% | $33.31 | -64.8% | COM NEW | 008064206 |
| ELVN | ENLIVEN THERAPEUTICS INC | 3,226,331 | $49.69M | 2.5% | $18.38 | +8.4% | COM | 29337E102 |
| ORIC | ORIC PHARMACEUTICALS INC | 5,676,230 | $46.43M | 2.3% | $7.60 | +51.4% | COM | 68622P109 |
| ENGN | ENGENE HOLDINGS INC | 4,771,414 | $43.09M | 2.1% | $10.25 | -21.8% | COM | 29286M105 |
| DYN | DYNE THERAPEUTICS INC | 2,173,913 | $42.52M | 2.1% | $11.80 | +60.5% | COM | 26818M108 |
| DNTH | DIANTHUS THERAPEUTICS INC | 1,000,000 | $41.21M | 2.0% | $18.52 | +109.3% | COM | 252828108 |
| UPB | UPSTREAM BIO INC | 1,169,298 | $31.75M | 1.6% | $22.33 | +11.5% | COM | 91678A107 |
| HELP | CYBIN INC | 3,840,250 | $31.41M | 1.6% | $6.44 | 0.0% | COM NEW | 23256X407 |
| ZURA | ZURA BIO LTD | 5,345,115 | $28.01M | 1.4% | $2.77 | +42.9% | CLASS A ORD SHS | G9TY5A101 |
| VOR | VOR BIOPHARMA INC | 1,943,766 | $25.42M | 1.3% | $24.17 | -23.0% | COM NEW | 929033207 |
| CBIO | CRESCENT BIOPHARMA INC. | 2,133,576 | $25.3M | 1.2% | $18.21 | -30.0% | COM | G2545C104 |
| SEPN | SEPTERNA INC | 610,808 | $17.03M | 0.8% | $8.80 | +171.5% | COM | 81734D104 |
| SRZN | SURROZEN INC | 632,931 | $14.3M | 0.7% | $11.62 | +39.2% | COM NEW | 86889P208 |
| CGEM | CULLINAN THERAPEUTICS INC | 1,379,965 | $14.28M | 0.7% | $21.29 | -57.6% | COM | 230031106 |
| ARTV | ARTIVA BIOTHERAPEUTICS INC | 1,609,569 | $6.905M | 0.3% | $11.59 | -67.4% | COM | 04317A107 |
| CASIF | CASI PHARMACEUTICALS INC | 987,259 | $839K | 0.0% | $6.09 | -78.8% | ORD SHS | G1933S101 |